Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study

[1]  N. Iwata,et al.  Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials , 2016, European Archives of Psychiatry and Clinical Neuroscience.

[2]  Kiyoshi Inoue,et al.  Variation in the Oxytocin Receptor Gene Predicts Brain Region–Specific Expression and Social Attachment , 2016, Biological Psychiatry.

[3]  G. Donohoe,et al.  Emotion and Theory of Mind in Schizophrenia—Investigating the Role of the Cerebellum , 2016, The Cerebellum.

[4]  R. Spanagel,et al.  Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence , 2016, Proceedings of the National Academy of Sciences.

[5]  T. Insel.  Translating Oxytocin Neuroscience to the Clinic: A National Institute of Mental Health Perspective , 2016, Biological Psychiatry.

[6]  D. Slattery,et al.  Oxytocin in General Anxiety and Social Fear: A Translational Approach , 2016, Biological Psychiatry.

[7]  A. Guastella,et al.  Oxytocin Treatment, Circuitry, and Autism: A Critical Review of the Literature Placing Oxytocin Into the Autism Context , 2016, Biological Psychiatry.

[8]  R. Hurlemann,et al.  Dissecting the Role of Oxytocin in the Formation and Loss of Social Relationships , 2016, Biological Psychiatry.

[9]  H. Morishita,et al.  Prefrontal Cortex and Social Cognition in Mouse and Man , 2015, Front. Psychol..

[10]  D. Javitt,et al.  Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia , 2015, The Journal of Neuroscience.

[11]  C. Pantelis,et al.  Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia , 2015, Schizophrenia Research.

[12]  Michael F. Green,et al.  Social cognition in schizophrenia , 2015, Nature Reviews Neuroscience.

[13]  H. Caldwell,et al.  A Role for Oxytocin in the Etiology and Treatment of Schizophrenia , 2015, Front. Endocrinol..

[14]  Jodi Zik,et al.  The many faces of oxytocin: Implications for psychiatry , 2015, Psychiatry Research.

[15]  J. Connelly,et al.  Plasma oxytocin explains individual differences in neural substrates of social perception , 2015, Front. Hum. Neurosci..

[16]  J. Kwon,et al.  Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia , 2015, Neuropsychopharmacology.

[17]  S. Djurovic,et al.  Association between Genetic Variation in the Oxytocin Receptor Gene and Emotional Withdrawal, but not between Oxytocin Pathway Genes and Diagnosis in Psychotic Disorders , 2015, Front. Hum. Neurosci..

[18]  R. Costa,et al.  Dopamine systems adaptation during acquisition and consolidation of a skill , 2014, Front. Integr. Neurosci..

[19]  Michael F. Green,et al.  Associations between oxytocin receptor genotypes and social cognitive performance in individuals with schizophrenia , 2014 .

[20]  M. Leonzino,et al.  Learning About Oxytocin: Pharmacologic and Behavioral Issues , 2014, Biological Psychiatry.

[21]  L. Young,et al.  Neuroanatomical distribution of oxytocin and vasopressin 1a receptors in the socially monogamous coppery titi monkey (Callicebus cupreus) , 2014, Neuroscience.

[22]  L. Young,et al.  The neuroanatomical distribution of oxytocin receptor binding and mRNA in the male rhesus macaque (Macaca mulatta) , 2014, Psychoneuroendocrinology.

[23]  Stephan Eliez,et al.  Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. , 2014, The American journal of psychiatry.

[24]  D. Slattery,et al.  Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice , 2014, Psychoneuroendocrinology.

[25]  M. Boccia,et al.  Immunohistochemical localization of oxytocin receptors in human brain , 2013, Neuroscience.

[26]  Masato Fukuda,et al.  Temporal lobe and inferior frontal gyrus dysfunction in patients with schizophrenia during face-to-face conversation: a near-infrared spectroscopy study. , 2013, Journal of psychiatric research.

[27]  R. Kahn,et al.  Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. , 2013, Schizophrenia bulletin.

[28]  D. Rujescu,et al.  Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: A case–control study , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[29]  Lydia Krabbendam,et al.  Trust versus paranoia: abnormal response to social reward in psychotic illness. , 2013, Brain : a journal of neurology.

[30]  R. Spanagel,et al.  Rescue of Infralimbic mGluR2 Deficit Restores Control Over Drug-Seeking Behavior in Alcohol Dependence , 2013, The Journal of Neuroscience.

[31]  I. Namer,et al.  Caudate nucleus and social cognition: Neuropsychological and SPECT evidence from a patient with focal caudate lesion , 2013, Cortex.

[32]  S. Poletti,et al.  Neurofunctional Correlates of Theory of Mind Deficits in Schizophrenia , 2012 .

[33]  T. Schneider-Axmann,et al.  The Sex-Dependent Impact of Chronic Clozapine and Haloperidol Treatment on Characteristics of the Metabolic Syndrome in a Rat Model , 2012, Pharmacopsychiatry.

[34]  A. Minassian,et al.  Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia , 2012, Schizophrenia Research.

[35]  Vaughan J. Carr,et al.  Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia , 2012, Neuroscience & Biobehavioral Reviews.

[36]  B. Lerer,et al.  Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree. , 2012, The international journal of neuropsychopharmacology.

[37]  P. Thompson,et al.  Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. , 2012, The international journal of neuropsychopharmacology.

[38]  D. Penn,et al.  Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia , 2011, Schizophrenia Research.

[39]  Peter Kirsch,et al.  Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine , 2011, Nature Reviews Neuroscience.

[40]  Andrew J. Rosenfeld,et al.  Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia. , 2011, Schizophrenia bulletin.

[41]  B. Averbeck,et al.  Emotion recognition and oxytocin in patients with schizophrenia , 2011, Psychological Medicine.

[42]  P. Falkai,et al.  The role of the cerebellum in schizophrenia: from cognition to molecular pathways , 2011, Clinics.

[43]  Tyrone D. Cannon,et al.  Pathophysiology of Schizophrenia , 2011 .

[44]  C. Carter,et al.  Peripheral oxytocin is associated with reduced symptom severity in schizophrenia , 2010, Schizophrenia Research.

[45]  S. Leucht,et al.  Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later , 2010, Dialogues in clinical neuroscience.

[46]  Stephen C. J. Parker,et al.  Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect , 2010, Human mutation.

[47]  H. Meltzer,et al.  Variants in the oxytocin gene and risk for schizophrenia , 2010, Schizophrenia Research.

[48]  Daniel R. Weinberger,et al.  A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function , 2010, Proceedings of the National Academy of Sciences.

[49]  J. Lieberman,et al.  Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes. , 2010, The international journal of neuropsychopharmacology.

[50]  K. Marquis,et al.  Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist , 2010, Neuropharmacology.

[51]  W. Young,et al.  Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice , 2009, Molecular Psychiatry.

[52]  N. Bargalló,et al.  Cerebellar deficits in schizophrenia are associated with executive dysfuntion , 2008, Neuroreport.

[53]  N. Andreasen,et al.  Theory of mind and schizophrenia: a positron emission tomography study of medication-free patients. , 2008, Schizophrenia bulletin.

[54]  T. Kinoshita,et al.  Cerebellar Posterior Superior Vermis and Cognitive Cluster Scores in Drug-Naive Patients with First-Episode Schizophrenia , 2008, Neuropsychobiology.

[55]  Chiara Gagliardi,et al.  Disorders of cognitive and affective development in cerebellar malformations. , 2007, Brain : a journal of neurology.

[56]  L. Young,et al.  IN THE NUCLEUS ACCUMBENS FACILITATE SPONTANEOUS ” MATERNAL BEHAVIOR IN ADULT FEMALE , 2006 .

[57]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[58]  Gareth Leng,et al.  Dendritic peptide release and peptide-dependent behaviours , 2006, Nature Reviews Neuroscience.

[59]  D. Dorsa,et al.  Social Interaction Deficits Caused by Chronic Phencyclidine Administration are Reversed by Oxytocin , 2005, Neuropsychopharmacology.

[60]  S. Woods,et al.  Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.

[61]  R. Adolphs.  Cognitive neuroscience: Cognitive neuroscience of human social behaviour , 2003, Nature Reviews Neuroscience.

[62]  T. Wassink,et al.  Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms , 1999, Biological Psychiatry.

[63]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[64]  F. Loup,et al.  Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study , 1991, Brain Research.

[65]  M. Rey,et al.  Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. , 1989, International clinical psychopharmacology.

[66]  C. Barberis,et al.  Topography of the oxytocin receptor system in rat brain: an autoradiographical study with a selective radioiodinated oxytocin antagonist. , 1988, Journal of chemical neuroanatomy.

[67]  G. Hommel.  A stagewise rejective multiple test procedure based on a modified Bonferroni test , 1988 .

[68]  R. Simes,et al.  An improved Bonferroni procedure for multiple tests of significance , 1986 .

[69]  Peter Kirsch,et al.  Social-Cognitive Deficits in Schizophrenia. , 2017, Current topics in behavioral neurosciences.

[70]  B. Averbeck,et al.  Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies. , 2015, Journal of psychiatry & neuroscience : JPN.

[71]  S. Chance,et al.  Differentiating between self and others: an ALE meta-analysis of fMRI studies of self-recognition and theory of mind , 2013, Brain Imaging and Behavior.

[72]  T. Svensson,et al.  Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats , 2005, Psychopharmacology.

[73]  J. Marengo,et al.  Classifying the courses of schizophrenia. , 1994, Schizophrenia bulletin.

[74]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[75]  J. Voogd,et al.  The Human Central Nervous System , 1978, Springer Berlin Heidelberg.